Rapport Therapeutics, Inc. · NASDAQ:RAPP

Ceesay Abraham sold 18,921 Rapport Therapeutics, Inc. shares (Form 4)

Traded Aug 25, 2026 · Filed Aug 26, 2026

On Aug 25, 2026, Ceesay Abraham (Director, Chief Executive Officer) sold 18,921 Rapport Therapeutics, Inc. shares at US$49.57 for US$938K under a trading plan, leaving 467,187 shares. Filed Aug 26, 2026 (Form 4).

Sold
18,921 shares
Price
US$49.57
Value
US$938K
Holding after
467,187 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 25, 2026Common StockSale18,921US$49.57467,187Direct

Source

View original at SEC

Related